-transparent.png){kind=logo}
1. The reliable antiphlogistic action of 2-(2-hydroxyethoxy)-ethyl-N-(a,a,a-trifluoro-m-tolyl)-anthranilate (etofenamate active principle of Rheumon Gel) in various experimental inflammatory models in animals is demonstrated following oral and cutaneous administration. 2. The proven inhibition of inflammatory edema by chronic administration of Rheumon gel evidences the percutaneous absorption of the active principle through the intact skin. 3. The effect of Rheumon gel sets in independently of whether the gel is applied to normal or to pathologically inflamed tissue areas. 4. Gastrointestinal mucous tolerance is better for etofenamate than for flufenamic acid, phenylbutazone and other anti-inflammatory drugs.
H Jacobi, and
P Breier, and
H D Dell, and
D Lorenz
January 1977,
Arzneimittel-Forschung,
H Jacobi, and
P Breier, and
H D Dell, and
D Lorenz
December 1981,
Praxis und Klinik der Pneumologie,
H Jacobi, and
P Breier, and
H D Dell, and
D Lorenz
January 1978,
Arzneimittel-Forschung,
H Jacobi, and
P Breier, and
H D Dell, and
D Lorenz
October 1981,
Planta medica,
H Jacobi, and
P Breier, and
H D Dell, and
D Lorenz
November 1981,
Planta medica,
H Jacobi, and
P Breier, and
H D Dell, and
D Lorenz
January 1981,
Arzneimittel-Forschung,
H Jacobi, and
P Breier, and
H D Dell, and
D Lorenz
April 1974,
Humangenetik,
H Jacobi, and
P Breier, and
H D Dell, and
D Lorenz
January 1978,
Arzneimittel-Forschung,
H Jacobi, and
P Breier, and
H D Dell, and
D Lorenz
January 1977,
Arzneimittel-Forschung,
H Jacobi, and
P Breier, and
H D Dell, and
D Lorenz
January 1977,
Arzneimittel-Forschung,
